One skirt size increase every 10 years elevates breast cancer risk
the ONA take:
According to a new study published in the journal BMJ Open, women whose skirt size increases one size every 10 years between their mid-20s and mid-60s have a 33% increased risk for developing breast cancer after menopause.
Researchers at University College London in London, United Kingdom, surveyed 92,834 women aged 50-69 years who were involved with the UK Collaborative Trial of Ovarian Cancer Screening about their present and previous skirt sizes. No participants had been diagnosed with breast cancer. On average, women had a skirt size of 8 at age 25 and a skirt size of 10 at age 64.
The researchers followed up with the women for 3 years and during that period, 1,090 women were diagnosed with breast cancer. The researchers estimated that the 5-year absolute risk of breast cancer in postmenopausal women increases with every one skirt size increase every 10 years.
In addition to the 33% increased risk for postmenopausal women whose skirt size increases one unit every decade, women whose skirt size increases two units every 10 years had a 77% increased risk for developing breast cancer post-menopause. They also found that body mass index did not help improve the prediction risk.
Women whose skirt size increases one size have increased risk for developing breast cancer.
Women who go up one skirt size every 10 years between their mid-20s and mid-60s are at a 33% greater risk of developing breast cancer after the menopause, new research has found.
Weight gain measured through an increase in body mass index (BMI) was known to be a risk factor, particularly around the midriff, but a study of 90,000 women is the first to make a connection between breast cancer and skirt size.
The results show that an expanding waistline could be more harmful. Those who went up by two sizes every decade in the same period saw an increased risk of 77%, according to the University College London study.The research could provide a valuable insight into breast cancer prevention.
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
- Vitamin D Supplementation is Recommended for Pediatric Patients With Sarcoma
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|